肾去神经联合肺静脉隔离术后房性心律失常负担的长期变化SYMPLICITY-AF.

IF 8 1区 医学 Q1 CARDIAC & CARDIOVASCULAR SYSTEMS JACC. Clinical electrophysiology Pub Date : 2024-09-01 DOI:10.1016/j.jacep.2024.04.035
{"title":"肾去神经联合肺静脉隔离术后房性心律失常负担的长期变化SYMPLICITY-AF.","authors":"","doi":"10.1016/j.jacep.2024.04.035","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><div>The autonomic nervous system plays an important role in atrial fibrillation<span> (AF) and hypertension. Renal denervation (RDN) lowers blood pressure (BP), but its role in AF is poorly understood.</span></div></div><div><h3>Objectives</h3><div>The purpose of this study was to investigate whether RDN reduces AF recurrence after pulmonary vein isolation (PVI).</div></div><div><h3>Methods</h3><div>This study randomized patients from 8 centers (United States, Germany) with drug-refractory AF for treatment with PVI+RDN vs PVI alone. A multielectrode radiofrequency Spyral catheter system was used for RDN. Insertable cardiac monitors were used for continuous rhythm monitoring. The primary efficacy endpoint was ≥2 minutes of AF recurrence or repeat ablation during all follow-up. The secondary endpoints included atrial arrhythmia<span> (AA) burden, discontinuation of class I/III antiarrhythmic drugs, and BP changes from baseline.</span></div></div><div><h3>Results</h3><div>A total of 70 patients with AF (52 paroxysmal, 18 persistent) and uncontrolled hypertension were randomized (RDN+PVI, n = 34; PVI, n = 36). At 3.5 years, 26.2% and 21.4% of patients in RDN+PVI and PVI groups, respectively, were free from the primary efficacy endpoint (log rank <em>P =</em> 0.73). Patients with mean ≥1 h/d AA had less daily AA burden after RDN+PVI vs PVI (4.1 hours vs 9.2 hours; <em>P =</em><span> 0.016). More patients discontinued class I/III antiarrhythmic drugs after RDN+PVI vs PVI (45% vs 14%; </span><em>P =</em><span> 0.040). At 1 year, systolic BP changed by −17.8 ± 12.8 mm Hg and −13.7 ± 18.8 mm Hg after RDN+PVI and PVI, respectively </span><em>(P =</em> 0.43). The composite safety endpoint was not significantly different between groups.</div></div><div><h3>Conclusions</h3><div>In patients with AF and uncontrolled BP, RDN+PVI did not prevent AF recurrence more than PVI alone. However, RDN+PVI may reduce AF burden and antiarrhythmic drug usage, but this needs further prospective validation.</div></div>","PeriodicalId":14573,"journal":{"name":"JACC. Clinical electrophysiology","volume":"10 9","pages":"Pages 2062-2073"},"PeriodicalIF":8.0000,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Long-Term Changes in Atrial Arrhythmia Burden After Renal Denervation Combined With Pulmonary Vein Isolation\",\"authors\":\"\",\"doi\":\"10.1016/j.jacep.2024.04.035\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><h3>Background</h3><div>The autonomic nervous system plays an important role in atrial fibrillation<span> (AF) and hypertension. Renal denervation (RDN) lowers blood pressure (BP), but its role in AF is poorly understood.</span></div></div><div><h3>Objectives</h3><div>The purpose of this study was to investigate whether RDN reduces AF recurrence after pulmonary vein isolation (PVI).</div></div><div><h3>Methods</h3><div>This study randomized patients from 8 centers (United States, Germany) with drug-refractory AF for treatment with PVI+RDN vs PVI alone. A multielectrode radiofrequency Spyral catheter system was used for RDN. Insertable cardiac monitors were used for continuous rhythm monitoring. The primary efficacy endpoint was ≥2 minutes of AF recurrence or repeat ablation during all follow-up. The secondary endpoints included atrial arrhythmia<span> (AA) burden, discontinuation of class I/III antiarrhythmic drugs, and BP changes from baseline.</span></div></div><div><h3>Results</h3><div>A total of 70 patients with AF (52 paroxysmal, 18 persistent) and uncontrolled hypertension were randomized (RDN+PVI, n = 34; PVI, n = 36). At 3.5 years, 26.2% and 21.4% of patients in RDN+PVI and PVI groups, respectively, were free from the primary efficacy endpoint (log rank <em>P =</em> 0.73). Patients with mean ≥1 h/d AA had less daily AA burden after RDN+PVI vs PVI (4.1 hours vs 9.2 hours; <em>P =</em><span> 0.016). More patients discontinued class I/III antiarrhythmic drugs after RDN+PVI vs PVI (45% vs 14%; </span><em>P =</em><span> 0.040). At 1 year, systolic BP changed by −17.8 ± 12.8 mm Hg and −13.7 ± 18.8 mm Hg after RDN+PVI and PVI, respectively </span><em>(P =</em> 0.43). The composite safety endpoint was not significantly different between groups.</div></div><div><h3>Conclusions</h3><div>In patients with AF and uncontrolled BP, RDN+PVI did not prevent AF recurrence more than PVI alone. However, RDN+PVI may reduce AF burden and antiarrhythmic drug usage, but this needs further prospective validation.</div></div>\",\"PeriodicalId\":14573,\"journal\":{\"name\":\"JACC. Clinical electrophysiology\",\"volume\":\"10 9\",\"pages\":\"Pages 2062-2073\"},\"PeriodicalIF\":8.0000,\"publicationDate\":\"2024-09-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"JACC. Clinical electrophysiology\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S2405500X24003839\",\"RegionNum\":1,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"CARDIAC & CARDIOVASCULAR SYSTEMS\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"JACC. Clinical electrophysiology","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2405500X24003839","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}
引用次数: 0

摘要

背景:自律神经系统在心房颤动(AF)和高血压中发挥着重要作用。肾脏神经支配(RDN)可降低血压(BP),但其在房颤中的作用却鲜为人知:本研究旨在探讨 RDN 是否能减少肺静脉隔离术(PVI)后房颤的复发:这项研究对来自 8 个中心(美国、德国)的药物难治性房颤患者进行了随机分组,让他们接受 PVI+RDN 与单纯 PVI 的治疗。RDN 采用多电极射频 Spyral 导管系统。插入式心脏监护仪用于连续心律监测。主要疗效终点是在所有随访期间房颤复发或重复消融时间≥2分钟。次要终点包括房性心律失常(AA)负荷、停用 I/III 类抗心律失常药物和血压与基线相比的变化:共有 70 名房颤患者(阵发性 52 人,持续性 18 人)和未控制的高血压患者接受了随机治疗(RDN+PVI,34 人;PVI,36 人)。3.5年后,RDN+PVI组和PVI组分别有26.2%和21.4%的患者未达到主要疗效终点(对数秩P = 0.73)。RDN+PVI组与PVI组相比,平均每日AA时间≥1小时的患者每日AA负担较轻(4.1小时 vs 9.2小时;P = 0.016)。RDN+PVI与PVI相比,停用I/III类抗心律失常药物的患者更多(45% vs 14%; P = 0.040)。1 年后,RDN+PVI 和 PVI 的收缩压变化分别为 -17.8 ± 12.8 mm Hg 和 -13.7 ± 18.8 mm Hg(P = 0.43)。各组间的复合安全性终点无明显差异:结论:对于房颤且血压未得到控制的患者,RDN+PVI 比单独使用 PVI 更能预防房颤复发。然而,RDN+PVI 可减少房颤负担和抗心律失常药物的使用,但这还需要进一步的前瞻性验证。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
Long-Term Changes in Atrial Arrhythmia Burden After Renal Denervation Combined With Pulmonary Vein Isolation

Background

The autonomic nervous system plays an important role in atrial fibrillation (AF) and hypertension. Renal denervation (RDN) lowers blood pressure (BP), but its role in AF is poorly understood.

Objectives

The purpose of this study was to investigate whether RDN reduces AF recurrence after pulmonary vein isolation (PVI).

Methods

This study randomized patients from 8 centers (United States, Germany) with drug-refractory AF for treatment with PVI+RDN vs PVI alone. A multielectrode radiofrequency Spyral catheter system was used for RDN. Insertable cardiac monitors were used for continuous rhythm monitoring. The primary efficacy endpoint was ≥2 minutes of AF recurrence or repeat ablation during all follow-up. The secondary endpoints included atrial arrhythmia (AA) burden, discontinuation of class I/III antiarrhythmic drugs, and BP changes from baseline.

Results

A total of 70 patients with AF (52 paroxysmal, 18 persistent) and uncontrolled hypertension were randomized (RDN+PVI, n = 34; PVI, n = 36). At 3.5 years, 26.2% and 21.4% of patients in RDN+PVI and PVI groups, respectively, were free from the primary efficacy endpoint (log rank P = 0.73). Patients with mean ≥1 h/d AA had less daily AA burden after RDN+PVI vs PVI (4.1 hours vs 9.2 hours; P = 0.016). More patients discontinued class I/III antiarrhythmic drugs after RDN+PVI vs PVI (45% vs 14%; P = 0.040). At 1 year, systolic BP changed by −17.8 ± 12.8 mm Hg and −13.7 ± 18.8 mm Hg after RDN+PVI and PVI, respectively (P = 0.43). The composite safety endpoint was not significantly different between groups.

Conclusions

In patients with AF and uncontrolled BP, RDN+PVI did not prevent AF recurrence more than PVI alone. However, RDN+PVI may reduce AF burden and antiarrhythmic drug usage, but this needs further prospective validation.
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
JACC. Clinical electrophysiology
JACC. Clinical electrophysiology CARDIAC & CARDIOVASCULAR SYSTEMS-
CiteScore
10.30
自引率
5.70%
发文量
250
期刊介绍: JACC: Clinical Electrophysiology is one of a family of specialist journals launched by the renowned Journal of the American College of Cardiology (JACC). It encompasses all aspects of the epidemiology, pathogenesis, diagnosis and treatment of cardiac arrhythmias. Submissions of original research and state-of-the-art reviews from cardiology, cardiovascular surgery, neurology, outcomes research, and related fields are encouraged. Experimental and preclinical work that directly relates to diagnostic or therapeutic interventions are also encouraged. In general, case reports will not be considered for publication.
期刊最新文献
Epilepsy and Cardiac Arrhythmias: A State-of-the-Art Review. Lead Integrity and Failure Evaluation in Left Bundle Branch Area Pacing (LIFE-LBBAP) Study. Home Sotalol Initiation for the Management of Atrial and Ventricular Arrhythmias Using Remote Electrocardiographic Monitoring. A Novel Computational Platform for Optimizing Synergistic Drug Combinations for Cardioversion of Atrial Fibrillation. Ventricular Tachycardia Ablation in the Emergency Setting: Walking on Thin Ice.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1